Kennedy selected a new team of medical professionals and scientists who are looking at vaccines are highly qualified.

An ecological study finds increased uptake of recommended childhood vaccines was associated with a 47% decrease in the rate ...

Sanofi is trailing behind GSK and Pfizer when it comes to vaccines for respiratory syncytial virus (RSV), but it still thinks it can be the top player in the market with a combination of its ...

The Centers for Disease Control and Prevention (CDC) yesterday declared its investigation into a multistate Salmonella ...

Adults as young as 50 may now qualify for an RSV vaccine if they have certain health conditions, according to a quiet update ...

The CDC already recommends the RSV shot for all adults 75 and older and for people 60 and older who have health conditions that increase their risk of severe RSV. It also recommends the shot during ...

Failure to recognize and resolve problems in an honest and evidence-based manner is the root cause of increasing vaccine ...

GSK's vaccine against respiratory syncytial virus (RSV) is one of the top prospects in its pipeline, but also one with considerable competition, so needs strong data to support the programme ...